Id-1 and the p65 subunit of NF-κB promote migration of nasopharyngeal carcinoma cells and are correlated with poor prognosis

Carcinogenesis

Volumn 33, Issue 4, 2012, Pages 810-817

  Sun, Wei ^a   Guo, Ming Ming ^b   Han, Ping ^a   Lin, Ji Zhen ^c   Liang, Fa Ya ^a   Tan, Guang Mou ^b   Li, Hua Bin ^a,d   Zeng, Musheng ^e   Huang, Xiao Ming ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF MINNESOTA   (United States)

^d THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^e SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; INHIBITOR OF DIFFERENTIATION 1; MESSENGER RNA; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR RELA;

ADULT; ARTICLE; BASEMENT MEMBRANE; CANCER INVASION; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CELL MIGRATION; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCHEMISTRY; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 84859590530     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs027     Document Type: Article

References (47)

1. Hirayama, T. (1978) Descriptive and analytical epidemiology of nasopharyngeal cancer. IARC Sci. Publ., 20, 167-189.
2. Lee, N. et al. (2002) Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int. J. Radiat. Oncol. Biol. Phys., 53, 12-22.
3. Chow, E. et al. (2002) Radiotherapy alone in patients with advanced nasopharyngeal cancer: comparison with an intergroup study. Is combined modality treatment really necessary? Radiother. Oncol., 63, 269-274.
4. Waldron, J. et al. (2003) Limitation of conventional two dimensional radiation therapy planning in nasopharyngeal carcinoma. Radiother. Oncol., 68, 153-161.
5. Lee, A. W. et al. (2010) Randomized trial of radiotherapy plus concurrentadjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma. J. Natl Cancer Inst., 102, 1188-1198.
6. Benezra, R. et al. (1990) The protein Id: a negative regulator of helix-loophelix DNA binding proteins. Cell, 61, 49-59.
7. Norton, J. D. et al. (1998) Coupling of cell growth control and apoptosis functions of Id proteins. Mol. Cell. Biol., 18, 2371-2381.
8. Norton, J. D. (2000) ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J. Cell Sci., 113, 3897-3905.
9. Ouyang, X. S. et al. (2002) Id-1 stimulates serum independent prostate cancer cell proliferation through inactivation of P16(INK4a)/pRB pathway. Carcinogenesis, 23, 721-725.
10. Alani, R. M. et al. (1999) Immortalization of primary human keratinocytes by the helix-loop-helix protein, Id-1. Proc. Natl Acad. Sci. USA, 96, 9637-9641.
11. Nickoloff, B. J. et al. (2000) Id-1 delays senescence but does not immortalize keratinocytes. J. Biol. Chem., 275, 27501-27504.
12. Lin, C. Q. et al. (2000) A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells. Cancer Res., 60, 1332-1340.
13. Maruyama, H. et al. (1999) Id-1 and Id-2 are overexpressed in pancreatic cancer and in dysplastic lesions in chronic pancreatitis. Am. J. Pathol., 155, 815-822.
14. Ouyang, X. S. et al. (2002) Over expression of ID-1 in prostate cancer. J. Urol., 167, 2598-2602.
15. Schoppmann, S. F. et al. (2003) Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer. Int. J. Cancer, 104, 677-682.
16. Schindl, M. et al. (2001) Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer. Cancer Res., 61, 5703-5706.
17. Schindl, M. et al. (2003) Level of id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors. Clin. Cancer Res., 9, 779-785.
18. Lyden, D. et al. (1999) Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature, 401, 670-677.
19. Wang, X. et al. (2002) Evidence of increased Id-1 expression and its role in cell proliferation in nasopharyngeal carcinoma cells. Mol. Carcinog., 35, 42-49.
20. Coussens, L. M. et al. (2002) Inflammation and cancer. Nature, 420, 860-867.
21. Karin, M. et al. (2002) NF-kappaB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer, 2, 301-310.
22. Karin, M. et al. (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol., 5, 749-759.
23. Mabuchi, S. et al. (2004) Inhibition of NF-kappa B increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models. J. Biol. Chem., 279, 23477-23485.
24. Wu, J. T. et al. (2005) The NF-kappa B/Ikappa B signaling system: a molecular target in breast cancer therapy. J. Surg. Res., 123, 158-169.
25. Shen, H. M. et al. (2009) NFkappaB signaling in carcinogenesis and as a potential molecular target for cancer therapy. Apoptosis, 14, 348-363.
26. Ling, M. T. et al. (2003) Id-1 expression promotes cell survival through activation of NF-κB signalling pathway in prostate cancer cells. Oncogene, 22, 4498-4508.
27. Li, B. et al. (2007) Id-1 activation of PI3K/Akt/NFκB signaling pathway and its significance in promoting survival of esophageal cancer cells. Carcinogenesis, 28, 2313-2320.
28. Ling, M. T. et al. (2006) The multiple roles of Id-1 in cancer progression. Differentiation, 74, 481-487.
29. Lin, J. et al. (2010) Inhibitor of differentiation 1 contributes to head and neck squamous cell carcinoma survival via the NF-κB/survivin and phosphoinositide 3-kinase/Akt signaling pathways. Clin. Cancer Res, 16, 77-87.
30. Song, L. B. et al. (2009) The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J. Clin. Invest., 119, 3626-3636.
31. Moon, K. C. et al. (2005) Expression of caveolin-1 in pleomorphic carcinoma of the lung is correlated with a poor prognosis. Anticancer Res., 25, 4631-4637.
32. Sorescu, D. et al. (2002) Superoxide production and expression of Nox family proteins in human atherosclerosis. Circulation, 105, 1429-1435.
33. Mannello, F. (2003) Effects of blood collection methods on gelatin zymography of matrix metalloproteinases. Clin. Chem., 49, 339-340.
34. Munaut, C. et al. (2003) Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1-MMP, MMP-2 and MMP-9 in human glioblastomas. Int. J. Cancer, 106, 848-855.
35. Sobin, L. H. et al. (1997) TNM Classification of Malignant Tumours 5th edn. John Wiley, New York, pp. 66-73. http://onlinelibrary.wiley.com/doi/1002/ijc.1379/?url_ver5Z39.88-2004&rft_val_fmt5info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre5bookitem&rft.btitle5TNM%20classification%20of%20malignant%20tumours&rft.spage566&rft.epage=73&rft.date51997&rtf.edition55th%20ed.&rfr_id5info%3Asid%2Fwiley.com%3AOnlineLibrary.
36. Ho, J. H. (1978) An epidemiologic and clinical study of nasopharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys., 4, 182-198.
37. Tang, R. et al. (2009) High Id1 expression is associated with poor prognosis in 237 patients with acute myeloid leukemia. Blood, 114, 2993-3000.
38. Li, B. et al. (2009) Id-1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3K/AKT signaling pathway. Int. J. Cancer, 125, 2576-2585.
39. Kamalian, L. et al. (2008) Increased expression of Id family proteins in small cell lung cancer and its prognostic significance. Clin. Cancer Res., 14, 2318-2325.
40. Iwatsuki, M. et al. (2009) Bone marrow and peripheral blood expression of ID1 in human gastric carcinoma patients is a bona fide indicator of lymph node and peritoneal metastasis. Br. J. Cancer, 100, 1937-1942.
41. Ma, N. et al. (2008) Reactive nitrogen species-dependent DNA damage in EBV-associated nasopharyngeal carcinoma: the relation to STAT3 activation and EGFR expression. Int. J. Cancer, 122, 2517-2525.
42. Thornburg, N. J. et al. (2003) Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma. Cancer Res., 63, 8293-8301.
43. Valentine, R. et al. (2010) Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-kappaB pathway in carcinoma cells by inhibiting IKK phosphorylation. Mol. Cancer, 9, 1.
44. Swarbrick, A. et al. (2005) Regulation of cyclin expression and cell cycle progression in breast epithelial cells by the helix-loop-helix protein Id1. Oncogene, 24, 381-389.
45. Desprez, P. Y. et al. (1998) A novel pathway for mammary epithelial cell invasion induced by the helix-loop-helix protein Id-1. Mol. Cell. Biol., 18, 4577-4588.
46. Fong, S. et al. (2003) Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis. Proc. Natl Acad. Sci. USA, 100, 13543-13548.
47. Minn, A. J. et al. (2005) Genes that mediate breast cancer metastasis to lung. Nature, 436, 518-524.